About
Apply
Sponsorship
2017_AHS_REP_logo

The Resident Education Program aims to provide early-stage adult and pediatric neurology residents (and other residency programs) with a foundation in headache medicine education led by experienced faculty in neurologic education and headache medicine.

We hope that this program will inspire a greater number of junior neurology trainees to consider pursuing careers in headache medicine.

2024 PROGRAM DETAILS

The American Headache Society’s 2024 Resident Education Program will be held in-person Friday, October 25 through Sunday, October 27 in Los Angeles, CA.

Faculty and residents will engage throughout the meeting in an interactive format that features lectures, small group sessions and workshops, and a friendly competition, as well as informally at combined faculty-resident meals and social events.

The Resident Education Program will:

  • Provide early stage adult and pediatric neurology residents with a foundation in headache medicine education.
  • Promote the exchange of information and ideas concerning the causes and treatments of headache and related painful disorders.
  • Introduce residents to experienced faculty in neurologic education and headache medicine.
  • Inspire a greater number of neurology residents to pursue careers in headache medicine.

Residents who participate in the Resident Education Program will be prepared to:

  • Diagnose and manage patients consulting for headache conditions, including the evidence-based use of pharmacologic, nonpharmacologic, procedural, and behavioral approaches
  • Differentiate where and how new therapies augment and improve the current standard of care in the acute and preventive treatment of migraine and other headache disorders
  • Engage in scholarly activity about migraine (e.g. teaching, research)

HEALTH AND SAFETY POLICY

The AHS actively monitors the health and safety guidance from the Centers for Disease Control as well as state and local health departments. We want attendees to enjoy a safe environment at all AHS meetings. While the AHS continues to recommend people are up to date on COVID-19 vaccination, attendees of AHS meetings are not required to be vaccinated or verify vaccination status. In addition, masks are optional for AHS meetings and prior antigen testing is not required. We will continue to follow best practices recommended by the Centers for Disease Control and Prevention and abide by any legal mandates and recommendations from government officials in the location of any AHS meeting. These protocols and information are subject to change.

Please note, even with safeguards and the AHS’s overarching commitment to attendee wellness, there remains a risk of contracting COVID-19.

Program Committee

Matthew S. Robbins, MD, FAHS, Chair
Weill Cornell Medical College
New York, NY

Deborah I. Friedman, MD, MPH, FAHS
UT Southwestern
Dallas, TX

Amy Gelfand, MD, MAS, FAHS
University of California San Francisco
San Francisco, CA

Peter J. Goadsby, MD, PhD, FAHS
University of California, Los Angeles
Los Angeles, CA

Melissa Rayhill, MD, FAHS
University at Buffalo Jacobs School of Medicine, The State University of New York
Williamsville, NY

Noah Rosen, MD, FAHS
Donald and Barbara Zucker School of Medicine Northwell Headache Center
Great Neck, NY

Niushen Zhang, MD, FAHS
Stanford University
Palo Alto, CA

 

2017_AHS_REP_logo

Application Criteria: 

  • Submit the online application form with the following supporting documents:
    • Completion of brief statement of interest (100-200 words)
    • CV
    • Letter of support from Program Director
      • Each program director may nominate only one early stage resident from their program (PGY1 or PGY2 for adult neurology, PGY1, PGY2, or PGY3 for child neurology, but if no such candidate is available a PGY3 adult neurology or PGY4 child neurology resident would be considered).
  • Applicant must be a resident in a US adult or pediatric neurology training program. We will also consider applications from trainees in other residency programs, including but not limited to internal medicine, family medicine, pediatrics, physiatry, obstetrics and gynecology, and orofacial pain. International applications are not eligible at this time.

Accepted participants will receive the following:

  • Reimbursement up to $1,500 for eligible travel expenses including:
    • Roundtrip coach/economy class travel
    • Ground transportation to/from airport and conference center (car rental and gas not covered)
    • Two nights’ accommodation at the conference hotel
  • Meals, which are included in the meeting, from Friday night through Sunday morning.
  • Complimentary one-year Trainee membership to the American Headache Society or extension of an existing AHS Trainee membership

2024 Application Timeline:

  • Monday, July 1: Applications open
  • Sunday, August 11: Applications due
  • On or about Monday, August 26: Final decisions to be distributed
2017_AHS_REP_logo

The American Headache Society gratefully acknowledges the support of the 2024 Resident Education Program from our industry supporters:

GOLD


Lilly unites caring with discovery to create medicines that make life better for people around the world. We’ve been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than 47 million people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world’s most significant health challenges, redefining diabetes care, treating obesity and curtailing its most devastating long-term effects, advancing the fight against Alzheimer’s disease, providing solutions to some of the most debilitating immune system disorders, and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we’re motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit lilly.com and lilly.com/newsroom or follow us on Facebook, Instagram, and LinkedIn.